Truvada (emtricitabine/tenofovir) to lower their risk of getting HIV

See the CDC's interim guidance for pre-exposure prophylaxis of HIV infection

You may have patients asking for Truvada (emtricitabine/tenofovir) to lower their risk of getting HIV.

Prophylaxis after exposure isn't new...it's standard practice for babies born to HIV-positive moms and people exposed to infected fluids.

Now there's evidence that CHRONIC prophylaxis reduces the risk of HIV infection in high-risk men who have sex with men.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote